SV Tech Ventures was established in 2015 by four tech industry veterans with a mission to empower early-stage promising innovations. Through many years of experience, our partners accumulated broad knowledge and extensive resources in both entrepreneurship and investments in various fields.
Since then, we have completed investments in over 70 high-tech high-touch companies through SV Tech Fund I, II & III. Most recent exits include This is L (Organic Personal Care Acquired by Procter & Gamble), Original Stitch Inc (Custom Shirts. Acquired by World Co.), NeuroVasc(Mechanical thrombectomy solution for brain revascularization. Acquired), and Turning Point Therapeutics (Targeted Cancer therapies. Publicly traded on Nasdaq), Arrinex(Medical Device Acquired by Stryker), Neuvector(Full lifecycle container security platform), Oculli(High resolution virtual AI software for image radar), Apexgen(clinical-stage biopharmaceutical company).
We have faith in companies that have successfully demonstrated their capabilities to develop advanced technologies, especially those protected by high barriers to entry and thus benefit from the market leadership positions. Born from innovations, these technology breakthroughs are deemed to have significant impacts on key industries and our society alike.